|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
CHEMOKINES
From the Department of Anatomy, Institute of Basic
Medical Sciences, University of Oslo, Norway.
Stromal cell-derived factor 1 A superfamily of chemotactic cytokines, known as
chemokines, induces the migration of leukocytes by promoting
endothelial cell adhesion and transmigration toward a chemokine
concentration gradient. Chemokines are small, secreted proteins of 8 to
10 kd and are subdivided into 4 families based upon a structurally
related cystein motif in the amino terminal end. These are CXC ( The Src family of tyrosine kinases is a closely related group of
nonreceptor tyrosine kinases that modulate a variety of
cellular functions.7 Most Src kinases consist of a unique
N-terminal domain followed by an Src homology-3 (SH3), an SH2, and a
catalytic domain.7 The Src kinase Lck is negatively
regulated by phosphorylation of the conserved C-terminal tyrosine
residue Tyr505 by the C-terminal Src kinase (Csk), while its
kinase activity is promoted by autophosphorylation of
Tyr394.8 The Src kinase Lck is confined to the lymphoid lineage,9 where it plays an important role in antigen
receptor signaling. A physical coupling between Lck and CD4 has been
found necessary for T-cell chemotaxis induced by the CD4 ligand
interleukin 16 (IL-16).10,11 Moreover, IL-16 has been
shown to induce an Lck-dependent inhibitory signal for CXCR4
chemotaxis, requiring the presence of the SH3 domain of
Lck.11 Also, direct stimulation of the T-cell receptor
inhibits CXCL12-induced chemotaxis,12 indicating a
cross-talk between the T-cell receptor and CXCR4.
Lck is a promising candidate for orchestrating the signaling pathways
necessary for chemotaxis. A recent report demonstrates that ZAP-70,
which is a substrate for Lck, regulates chemotaxis induced by
CXCL12,13 indicating a possible role for Lck in the signaling pathway leading to chemotaxis. ZAP-70 activation is suggested
to be a necessary link to further downstream effectors such as the
phosphatidylinositol-3 kinases (PI3 kinases),14 which are
also implicated in the migrational response.15,16 It has
been demonstrated that both the SH2 and the SH3 domains of Lck
associate with a number of proteins implicated in the actin cytoskeletal reorganization events necessary for a migrational response, in particular the PI3 kinase, c-Cbl, and
Vav.17-19 Also, Lck has been shown to be necessary for
both CXCR4- and CD3-mediated activation of Different Src kinases have recently been implicated in the signaling
events leading to chemotaxis. In neutrophils, the Src kinases Hck and
c-Fgr are essential for migration, while the Src kinase Lyn is required
for chemotaxis of primary hematopoietic cells.22,23
Although Lck is required for chemotaxis induced through CD4, it is not
known whether Lck plays a similar role in chemotaxis mediated directly
through chemokine receptors such as CXCR4. Here, we addressed the
significance of Lck in CXCL12-induced chemotaxis of human T and NK
cells. Through the use of a specific Lck inhibitor and the
Lck-deficient cell line JCaM1.6, we demonstrate a novel role for Lck in
CXCL12-induced chemotaxis, requiring the kinase activity of Lck as well
as an intact SH3 domain.
Reagents and materials
Cell cultures and cell lines
Chemotaxis assay Blind-well chemotaxis chambers with a lower-well volume of 200 µL were used. We placed 200 µL RPMI medium containing 1% bovine serum albumin (BSA) in the lower wells in the presence or absence of CXCL12. Cells (4 × 105/100 µL NK cells, Jurkat cells, and JCaM1.6 cells and 1 × 106/100 µL T cells) were placed in the upper compartments of Boyden chambers above the filters. The chambers were incubated for 2 hours at 37°C in a 5% CO2 incubator. The filters were removed, dehydrated, fixed for 3 minutes in methanol, and stained with 15% Giemsa stain for 10 minutes. Cells in 10 high-power fields from 4 to 6 filters were counted and averaged for each sample. The migration index was calculated as the number of cells migrating toward the concentration gradient of chemokines divided by the number of cells migrating toward medium only.Immunoprecipitation and immunoblotting Cells were washed in RPMI containing 10 mM Hepes and resuspended in the same buffer. The cells were stimulated with CXCL12 at 37°C and lysed 1:1 vol on ice in 2 × NP-40 lysis buffer (2% Nonidet P-40; 50 mM Tris; 300 mM NaCl; 2 mM sodium orthovanadate; 20 mM NaF; and 2 mM phenylmethyl sulfonyl fluoride). The optimal concentration of CXCL12 was found to be 200 ng/mL for T cells and 80 ng/mL for NK cells. This could be due to higher-affinity CXCR4 receptors on activated NK cells, as compared with resting T cells. Cell lysates were clarified by centrifugation at 10 000 rpm for 10 minutes, then precleared with Protein G PLUS agarose beads for 30 minutes. The precleared lysates were immunoprecipitated for 2 hours with agarose conjugated with antiphosphotyrosine (PY99) (Santa Cruz Biotechnology). The immunoprecipitates were washed 3 times in 1 × NP-40 lysis buffer, separated on 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels (BioRad, Uppsala, Sweden), and transferred to PVDF membranes (Millipore, Bedford, MA). The membranes were blocked for 30 minutes in 3% BSA or 5% skimmed milk, incubated with primary antibodies for 2 hours and with 1:5000 dilution of horseradish peroxidase-conjugated secondary antibodies (Jackson Immunotech, West Grove, PA) for 1 hour. Proteins were detected by means of Supersignal (Pierce, Rockford, IL).Lck kinase assay Cells (4 × 107/mL) were stimulated with CXCL12 at 37°C and lysed 1:1 vol on ice in 2 × NP-40 lysis buffer. Lck was immunoprecipitated from the lysates with monoclonal anti-Lck antibody (3A5) for 3 hours and Protein A/G PLUS agarose beads for 1 hour. One sample was immunoprecipitated with beads only as a background control. The immunoprecipitates were washed twice in lysis buffer and twice in kinase reaction buffer (100 mM Tris-HCl, pH 7.2, 125 mM MgCl2, 25 mM MnCl2, 2 mM ethyleneglycotetraacetic acid, 0.25 mM sodium orthovanadate, and 2 mM dithiothreitol). Two thirds of the purified Lck was added to 150 µM Src-family substrate peptide ([Lys19]cdc2(6-20)-NH2). Then, 100 µCi (3.7 MBq) [ -32P]-adenosine
5'-triphosphate ([-32P]-ATP) (3000 Ci/mmol [110
TBq/mmol]) (Amersham Pharmacia Biotech, Uppsala, Sweden), 500 µM ATP, and kinase reaction buffer were added to a total of 40 µL.
The mixture was incubated for 10 minutes at 30°C. The peptide was
precipitated with 20 µL 40% trichloroacetic acid for 5 minutes at 30°C, transferred to P81 paper (Whatman, Maidstone,
England), and washed twice in 0.75% phosphoric acid and once in
acetone. The filters were counted in a scintillation counter. Kinase
activity in stimulated samples was calculated as an increase in
-32P incorporation compared with unstimulated samples.
The remaining one third of the immunoprecipitated Lck was run on an
SDS-PAGE gel, followed by anti-Lck immunoblotting to verify the
immunoprecipitation of Lck.
Flow cytometric analysis For the detection of CXCR4, JCaM1.6 cells (5 × 105 per sample) were stained with 1 µg anti-CXCR4 monoclonal antibody, or mouse immunoglobulin G as a control, for 45 minutes at 4°C. The cells were washed 3 times and then incubated 1:100 with a secondary rabbit anti-mouse phycoerythrin-conjugated antibody (Jackson Immunotech) for 30 minutes at 4°C. The samples were washed and examined in a FACS (Becton Dickinson, Mountain View, CA) flow cytometer.Transient cell transfection JCaM1.6 cells were washed once in Opti-MEM (Life Technologies) prior to transient transfection. Transfection was performed by electroporating 2 × 107 cells in 0.4 mL Opti-MEM mixed with 8 µg each DNA construct, in electroporation cuvettes with 0.4-cm electrode gap (BioRad). The cells were subjected to a field of 240 V/cm with 960 µF capacitance. The electroporated cells were expanded in complete medium with 10% fetal calf serum and harvested after 20 to 24 hours.DNA constructs The pEF-Neo vectors containing human Lck wild-type (wt) or Lck Tyr505Phe, and pEF-BOS/HA vectors containing human Csk were kind gifts from Dr K. Taskén (University of Oslo, Norway) and are as recently described.24 The Lck SH2 Arg154Lys or the Lck SH3 Trp98Ala were prepared by using the Stratagene QuickChange site-directed mutagenesis kit (Cedar Creek, TX) according to the manufacturer's instructions. The primers used were as follows: forward SH3, 5'-G-AGC-GGC-GAG-TGG-GCG-AAG-GCG-CAG-TC-3'; reverse SH3, 5'-GA-CTG-CGC-CTT-CGC-CCA-CTC-GCC-GCT-C-3'; forward SH2, 5'-C-GGC-TCC-TTC-CTC-ATC-AAA-GAG-AGC-GAG-AGC-ACC-G-3'; reverse SH2, 5'-C-GGT-GCT-CTC-GCT-CTC-TTT-GAT-GAG-GAA-GGA-GCC-G-3'. Constructs were verified by sequencing.Statistical analysis Data were analyzed with the unpaired Student t test.
The specific Lck inhibitor, damnacanthal, reduces CXCL12-induced lymphocyte chemotaxis The signaling pathways leading from chemokine receptor activation to cell migration have not yet been fully elucidated. Nonreceptor tyrosine kinases, in particular the Src-family tyrosine kinases, have recently been implicated in the early signaling events after activation of G protein-coupled chemokine receptors.25 As the chemokine receptor CXCR4 is one of the most abundantly expressed chemokine receptors on both T and NK cells,5,26 we studied the role of Src kinases in chemotaxis induced by the CXCR4 ligand CXCL12 (SDF-1 ).
In Figure 1, the effect of 3 different
inhibitors of nonreceptor tyrosine kinases on T- and NK-cell chemotaxis
was studied. CXCL12 was used at 25 ng/mL, a concentration that is
within the optimal response range for T lymphocytes.27
Pretreating T cells with herbimycin A (HA), a general Src tyrosine
kinase inhibitor, greatly reduced CXCL12-induced chemotaxis at 10 and
100 nM (P < .005 and P < .001,
respectively), and the chemotactic response was almost totally
abrogated at 1 µM concentration (P < .003; Figure 1A).
This result indicated the importance of one or more Src-family kinases
in CXCL12-induced chemotaxis of T cells. In contrast, chemotaxis
induced by CXCL12 does not seem to depend on the Syk tyrosine kinase,
another family of nonreceptor tyrosine kinases, as the Syk kinase
inhibitor piceatannol (PC) did not reduce the chemotactic response even
at 1 µM concentration. To dissect the type of Src kinase involved in
the chemotactic response, we used a specific inhibitor of the Lck
kinase, damnacanthal (DC).28 At 100 and 1000 nM DC,
CXCL12-induced chemotaxis was greatly reduced (P < .001
and P < .003, respectively), indicating that the Src kinase Lck is important for chemotaxis. We did not use activated T
cells since most known T-cell stimuli also activate
Lck.10-12
Similar results were obtained with NK cells. While untreated NK cells showed a clear chemotactic response to CXCL12, this was inhibited by pretreating NK cells with 10 and 100 nM HA (P < .03 and P < .02, respectively; Figure 1B). PC, on the other hand, did not significantly reduce the chemotactic response to CXCL12 even at 100 nM. Using the Lck inhibitor DC at 1 nM concentration did not significantly reduce the chemotactic response toward CXCL12. However, increasing the concentration of DC to 10 and 100 nM reduced the chemotactic response (P < .07 and P < .03, respectively). Collectively, these results point toward a role for Lck in CXCL12-induced chemotaxis in both T and NK cells. Stimulation of T and NK cells with CXCL12 induces tyrosine phosphorylation of Lck As Lck appears to be involved in CXCL12-induced chemotaxis of T cells and NK cells, we examined whether CXCL12 induces tyrosine phosphorylation of Lck in these cells. T cells and NK cells were stimulated with CXCL12 for 0 to 10 minutes. Figure 2 demonstrates a rapid enhancement of tyrosine phosphorylation of several proteins in both T cells (panel A) and NK cells (panel C) after 1-minute stimulation with CXCL12. Phosphorylation was especially pronounced for proteins of molecular masses of approximately 120, 75, 50 to 60, 40, and 30 kd. These phosphoproteins probably represent members of the focal adhesion complex, tyrosine kinases and MAP kinases that have been previously described in CXCL12-induced signaling pathways.3,15,29 The general tyrosine phosphorylation response was transient in both lymphocyte subsets, as it decreased after 5 to 10 minutes of stimulation.
To examine whether one of the CXCL12-induced phosphorylated bands was the p56lck kinase, the filters were stripped and reblotted with an antibody toward Lck. The lower panel in Figure 2A shows a sharp increase in tyrosine phosphorylation of Lck from 0 to 1 minute in T cells, which then markedly decreased after 5 minutes of CXCL12-stimulation. A more direct demonstration of Lck tyrosine phosphorylation is shown in Figure 2B where T cells stimulated with CXCL12 are immunoprecipitated with an antibody against Lck and then immunoblotted with antiphosphotyrosine. Lck showed the same tyrosine phosphorylation pattern as seen with the phosphotyrosine immunoprecipitation in Figure 2A. The Lck phosphorylation appears to be biphasic, as the tyrosine phosphorylation content of Lck increased again after 10 minutes. An equal amount of Lck in the different lanes is demonstrated in Figure 2B, lower panel. Also in NK cells, CXCL12 induced a general increase in tyrosine-phosphorylated proteins after 1-minute stimulation with CXCL12 (Figure 2C, upper panel). A phosphorylated protein at approximately 56 kd was observed when the phosphotyrosine immunoblot was stripped and reblotted with anti-Lck (Figure 2C, lower panel). Reciprocally, when immunoprecipitating Lck after stimulation of NK cells with CXCL12 and immunoblotting it with antiphosphotyrosine, we were able to demonstrate phosphorylation of a band corresponding to Lck (Figure 2D, upper panel). Maximum tyrosine phosphorylation of Lck in NK cells appears to be after 1 minute of stimulation with CXCL12. Equal amount of Lck in each lane is demonstrated (Figure 2D, lower panel). CXCL12 induces kinase activity of Lck in T and NK cells As phosphorylation of Lck can either activate or inhibit its enzymatic activity, we performed Lck kinase activity assays with either unstimulated or CXCL12-stimulated T cells or NK cells. As shown in Figure 3A, CXCL12 increased the kinase activity of Lck in T cells after 1 minute of stimulation (P < .05 compared with unstimulated cells), which slowly declined back to basal levels after 10 minutes. In NK cells, the Lck kinase activity increased markedly after 1 minute of CXCL12 stimulation (P < .05 compared with unstimulated cells), then returned to basal levels (Figure 3B).
T and NK cells were next pretreated with kinase inhibitors prior to performing Lck kinase assays. In Figure 3C, we demonstrate that pretreatment with 1 µM of both HA and DC inhibits the Lck kinase activity in T cells (P < .03 and P < .02, respectively), as opposed to pretreatment with 1 µM of the Syk inhibitor PC. Pretreating NK cells with 100 nM DC inhibited CXCL12-induced kinase activity of Lck (P < .01; Figure 3D), comparable to untreated cells. In contrast, the Syk kinase inhibitor PC (100 nM) did not significantly block Lck kinase activity. The Lck-deficient T-cell line JCaM1.6 does not migrate in response to CXCL12 To further evaluate the role of Lck in CXCL12-induced chemotaxis, we extended the studies to the mutant Jurkat T-cell line JCaM1.6, which lacks functional Lck.30 The parental Jurkat cell line E6.1 behaved similarly to T and NK cells when treated with the different tyrosine kinase inhibitors prior to chemotaxis toward CXCL12. Previous work has shown optimal migration of Jurkat cells in response to CXCL12 to be in the range of 10 to 100 ng/mL.13,27 Figure 4A shows that chemotaxis of Jurkat cells induced by 25 ng/mL CXCL12 was almost completely inhibited upon pretreatment with either 1 µM HA (P < .007) or 1 µM DC (P < .009). In contrast, PC did not affect Jurkat cell chemotaxis.
To compare CXCL12-induced chemotaxis in the Lck-deficient JCaM1.6 cells and Lck-reconstituted JCaM1.6 cells, we transiently transfected the JCaM1.6 cell line with either a wt Lck construct or an empty vector. Almost comparable levels of CXCR4 expression in both Lck-deficient and Lck-reconstituted JCaM1.6 cells were detected (Figure 6C), ruling out the possibility that any difference in chemotaxis might be due to a variation in CXCR4 expression. A successful transfection of Lck was demonstrated by a Western blot analysis (Figure 4B, insert). Also, we wanted to ascertain that the reintroduced wt Lck was enzymatically intact. Hence, an Lck kinase activity assay was performed with the wt Lck-transfected JCaM1.6 cells. As demonstrated in Figure 4B, cells transfected with Lck wt, and stimulated with CXCL12 for 1 minute, showed a marked increase in Lck kinase activity as compared with unstimulated Lck-transfected cells. No Lck kinase activity was observed above the background activity in CXCL12-stimulated JCaM1.6 cells transfected with an empty vector. Lck-transfected cells pretreated with 100 nM DC prior to stimulation with CXCL12 showed a decrease in the kinase activity as compared with DC-untreated cells (P < .05; Figure 4B). These results demonstrate a fully active Lck kinase after transfection of its construct into JCaM1.6 cells and show that CXCL12 is able to activate Lck in these cells. The migratory behavior of Lck-deficient JCaM1.6 cells and Lck-transfected JCaM1.6 cells was compared in a chemotaxis assay toward CXCL12. We used CXCL12 at 25 ng/mL, the same concentration we used for the chemotactic assays with the parental E6.1 cell line. Figure 4C demonstrates that JCaM1.6 cells transfected with the empty vector migrated poorly in response to CXCL12. On the other hand, when these cells were being transiently transfected with wt Lck, a clear chemotactic response was observed (P < .005, compared with cells transfected with empty vector). When cells transfected with the wt Lck were pretreated with 100 nM DC or PC, the cells pretreated with PC still migrated potently, whereas cells pretreated with DC showed a low chemotactic response as compared with cells not treated with DC (P < .009). Csk inhibits CXCL12-induced chemotaxis Csk negatively regulates Lck by phosphorylation of the C-terminal tyrosine residue Tyr505.31 To study the effect of Csk on CXCL12-induced chemotaxis, JCaM1.6 cells were transfected with an empty vector or the wt Lck construct in combination with an HA-tagged version of Csk. Figure 5 demonstrates that cotransfection of Csk with wt Lck abrogates the chemotactic response as compared with cells transfected with wt Lck alone (P < .01). We next studied the effect of a mutated version of Lck, where the tyrosine at position 505 had been point mutated to phenylalanine (Tyr505Phe). As Csk cannot phosphorylate this mutated version of Lck, Lck Tyr505Phe is constitutively active. To further demonstrate the negative regulation of Lck by Csk, we transfected JCaM1.6 cells with Lck Tyr505Phe in combination with Csk. While cotransfection of Csk with wt Lck abrogated the chemotactic response to CXCL12, cotransfection of Csk with Lck Tyr505Phe had no inhibitory effect on the CXCL12-induced chemotactic response, reflecting that Lck Tyr505Phe is under no negative regulation (Figure 5A). Also, a robust chemotactic response toward CXCL12 with the use of the Lck Tyr505Phe construct alone was observed (Figure 5A). JCaM1.6 cells cotransfected with Csk and an empty vector had no effect on chemotaxis induced by CXCL12 (Figure 5A). Control immunoblots of Csk and Lck were performed to ascertain successful transfections (Figure 5B). The upper panel in Figure 5B shows the presence of Lck in JCaM1.6 cells transfected with either Lck wt or Lck Tyr505Phe. The lower panel demonstrates the presence of transfected Csk, detected with an anti-HA antibody. The above results indicate a specific requirement of Lck, as Csk cannot inhibit the chemotactic response of cells expressing a constitutively active version of Lck, suggesting that Csk in this particular signaling pathway specifically regulates Lck and no other Src kinase.
The SH3 domain of Lck is important for CXCL12-induced chemotaxis Both SH2- and SH3-domain intermolecular and intramolecular interactions are proposed to regulate the kinase activity of the Src-family kinases.32 Therefore, we examined the effect of point mutations in either the SH2 or the SH3 domain of Lck on CXCL12-induced chemotaxis. The SH2 domain was point mutated in a single amino acid in position 154, from arginine to lysine (Arg154Lys), whereas the SH3 domain was point mutated in position 98, from tryptophane to alanine (Trp98Ala; Figure 6A). Vectors expressing the 2 Lck mutants, wt Lck, or an empty vector were transiently transfected into the JCaM1.6 cells. The different Lck constructs were expressed at equal levels (Figure 6B). Also, CXCR4 was expressed similarly in all transfectants at levels comparable to untransfected cells (Figure 6C). The ability of Lck-deficient cells transiently transfected with the 2 Lck mutants to migrate toward CXCL12 was assessed in a chemotaxis assay. As shown in Figure 6D, the chemotactic response to CXCL12 was almost completely abrogated in cells expressing the Lck SH3 mutant, as compared with transfectants expressing the Lck SH2 mutant (P < .02) or the Lck wt (P < .004).
The main role of Lck in T lymphocytes has traditionally been seen as the part it plays in the T-cell receptor complex through its association with CD4.33 A recent report, however, links Lck directly to G protein-coupled receptors, demonstrating that Lck can associate with other types of signaling receptor complexes in T cells.34 There is now accumulating evidence for a role of the different members of the Src-family tyrosine kinases in signaling events mediated through the G protein-coupled chemokine receptors. Stimulation of the neutrophil respiratory burst by chemoattractants is blocked by tyrosine kinase inhibitors, suggesting that one or more tyrosine kinases regulate the activity of critical signaling pathways used by these chemoattractants.35 We report in this paper that HA, a general Src-family inhibitor, and DC, a specific inhibitor of the Lck kinase, greatly reduce the chemotactic response of T cells and NK cells to CXCL12. We excluded the possibility that the observed inhibitory effect of either HA or DC is due to cytotoxic effects of the inhibitors by routinely performing trypan blue tests after inhibitor treatment. The inhibitory effect of the general Src kinase inhibitor and the specific Lck inhibitor is in line with other recent reports describing Src tyrosine kinases as central signaling molecules mediating migration. A study on CCL11 (eotaxin)-induced chemotaxis through the CCR3 receptor demonstrated an inhibitory effect of HA on eosinophil chemotaxis.36 Another study of eosinophils showed that PP1, a selective inhibitor of the Src kinases, abrogated the chemotactic response to the chemoattractant factor leukotriene B4.37 Also, mice deficient in Hck and Fgr demonstrate a reduced neutrophil migration into liver tissues, indicating a role of these kinases in neutrophil migration.23 An increased tyrosine phosphorylation of Lck after 1 minute of CXCL12 treatment of T cells and NK cells was observed. Su and coworkers38 have suggested that Lck is not tyrosine phosphorylated by CXCL12 in human CD4+ T cells. This was after 5 minutes of stimulation with CXCL12, however, and our results suggest that Lck phosphorylation in T cells is low after 5 minutes of CXCL12 stimulation prior to a second phase of tyrosine phosphorylation occurring after 10 minutes. Other groups also observed a biphasic tyrosine phosphorylation of Src kinases. In monocytes, Lyn is tyrosine phosphorylated with an initial peak after 30 seconds to 1 minute and a second peak after 10 to 30 minutes in response to soluble E-selectin.39 Also, the chemokine CCL2 (MCP-1) activates Src with an early peak at 1 to 2 minutes and a second peak after 15 minutes in monocytes.40 In NK cells, however, Lck tyrosine phosphorylation decreases gradually from 1 minute to 10 minutes of stimulation with CXCL12, corresponding to the observed time curve for Lck kinase activity in these cells. The observed biphasic Lck tyrosine phosphorylation in T cells was not observed in NK cells. This discrepancy between Lck phosphorylation in T cells and NK cells may reflect different signaling molecules that are active in these 2 cell types. CXCL12 induces Lck kinase activity in both T cells and NK cells,
reaching a maximum as early as 1 minute after stimulation in both cell
types. This corresponds well with the observed increase in Lck tyrosine
phosphorylation after 1 minute. A study on T cells has demonstrated
that a physical coupling of Lck with CD4 is necessary for
IL-16-induced migration. The enzymatic activity of Lck was not found
to be necessary, as pretreatment with HA did not block chemotaxis.10 In contrast, the enzymatic activity of Lck
seems to be essential for chemotaxis mediated through CXCR4 since
CXCL12 induces Lck kinase activity and since CXCL12-induced Lck kinase activity and chemotaxis are inhibited by HA or DC in both T and NK
cells. Gu et al34 have demonstrated that Lck increased its kinase activity after 1-minute treatment of S49 mouse lymphoma T cells
with isoproterenol toward the Both Jurkat T cells and an Lck-deficient Jurkat mutant, JCaM1.6,
express the CXCR4 chemokine receptor at similar levels.12 Previous analyses of JCaM1.6 cells have illustrated that the ability of
CD4 signaling to enhance Csk is the natural inhibitor of the Src kinase family in lymphocytes. By phosphorylating a tyrosine residue in the C-terminal tail of the kinases, it shuts down the enzymatic activity. We found that cotransfection of Csk with wt Lck leads to an inhibition of the CXCL12-induced chemotactic response observed in JCaM1.6 cells transfected with wt Lck only. The ability of Csk to block the chemotactic response clearly illustrates the that Src kinases are required in the initiation of a migrational signal. Furthermore, this suggests that release from Csk-mediated inhibition is a prerequisite for activation of a chemotactic response through chemokine receptors like CXCR4. The negative regulation by Csk of Lck in T-cell migration is thus similar to the role that these 2 signaling molecules play in T-cell receptor signaling. Collectively, these results point to a role for Lck in the signaling pathways leading to chemotaxis. We demonstrate that a point mutation in an essential amino acid in the
SH3 domain, but not the SH2 domain, of Lck abrogates the chemotactic
response to CXCL12. Lck associates with and activates a number of
downstream-signaling effectors through both its SH3 and its SH2
domains. Thus, the dramatic effect of just the mutated SH3 domain was
somewhat surprising. This result could indicate that Lck SH3 domain
interactions are critical for performing its task in the signaling
transduction events. Actin reorganization and integrin activation are
important events that lead to cell motility. Lck has been reported to
bind proteins important for actin reorganization, such as c-Cbl,
Ras-GTPase-activating protein, protein kinase C In summary, our study provides new information regarding the signaling pathways initiated by chemokine receptors leading to chemotaxis. Treating T cells or NK cells with the specific Lck inhibitor DC almost completely abrogated the chemotactic response to CXCL12. Also, stimulation with CXCL12 leads to phosphorylation and activation of Lck in both T and NK cells. The Lck-deficient Jurkat T-cell line, JCaM1.6, does not migrate in response to CXCL12, while reintroduction of wt Lck into these cells restores the chemotactic response. Both DC and Csk inhibit the chemotactic response of JCaM1.6 cells reconstituted with wt Lck. Further, we demonstrate that the Lck SH3 domain appears to be essential for chemotaxis. The almost similar results obtained with T cells and NK cells, in regard to the role of Lck in CXCL12-induced chemotaxis, strongly suggest that this could be a general mechanism used by CXCR4 and perhaps other chemokine receptors in lymphocytes. It remains to be seen what sorts of associations take place between this pathway and other intracellular signaling cascades induced by CXCL12 in other cell types.3,15,29
We thank Yenan Bryceson and Erik Dissen for valuable help in creating the Lck constructs and John Torgils Vaage for critically reading the manuscript.
Submitted November 5, 2001; accepted February 14, 2002.
Supported by grants from the Norwegian Research Council, the Norwegian Cancer Society, and Anders Jahre's Foundation; A.A.M. is a senior scientist of the Norwegian Cancer Society.
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734.
Reprints: Marit Inngjerdingen, Department of Anatomy, Institute of Basic Medical Sciences, University of Oslo, PO Box 1105 Blindern, N-0317 Oslo, Norway; e-mail: marit.inngjerdingen{at}basalmed.uio.no.
1.
Luster AD.
Chemokines: chemotactic cytokines that mediate inflammation.
N Engl J Med.
1998;338:436-445 2. Stantchev TS, Broder CC. Human immunodeficiency virus type-1 and chemokines: beyond competition for common cellular receptors. Cytokine Growth Factor Rev. 2001;12:219-243[CrossRef][Medline] [Order article via Infotrieve].
3.
Zhang X-F, Wang J-F, Matczak E, Proper J, Groopman JE.
Janus kinase 2 is involved in stromal cell-derived factor-1
4.
Bleul CC, Fuhlbrigge RC, Casanovas JM, Springer TA.
A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1).
J Exp Med.
1996;184:1101-1109
5.
Inngjerdingen M, Damaj B, Maghazachi AA.
Expression and regulation of chemokine receptors in human natural killer cells.
Blood.
2001;97:367-375
6.
Maghazachi AA.
Role of the heterotrimeric G proteins in stromal-derived factor-1 7. Thomas SM, Brugge JS. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol. 1997;13:513-609[CrossRef][Medline] [Order article via Infotrieve]. 8. Sicheri F, Kuriyan J. Structures of Src-family tyrosine kinases. Curr Opin Struct Biol. 1997;7:777-785[CrossRef][Medline] [Order article via Infotrieve].
9.
Lowell C, Soriano P.
Knockouts of Src-family kinases: stiff bones, wimpy T cells, and bad memories.
Genes Dev.
1996;10:1845-1857
10.
Ryan TC, Cruikshank WW, Kornfeld H, Collins TL, Center DM.
The CD4-associated tyrosine kinase p56lck is required for lymphocyte chemoattractant factor-induced T lymphocyte migration.
J Biol Chem.
1995;270:17081-17086
11.
Van Drenth C, Jenkins A, Ledwich L, et al.
Desensitization of CXC chemokine receptor 4, mediated by IL-16/CD4, is independent of p56lck enzymatic activity.
J Immunol.
2000;165:6356-6363
12.
Peacock JW, Jirik FR.
TCR activation inhibits chemotaxis toward stromal cell-derived factor-1: evidence for reciprocal regulation between CXCR4 and the TCR.
J Immunol.
1999;162:215-223
13.
Ottoson NC, Pribila JT, Chan ASH, Shimizu Y.
Cutting edge: T cell migration regulated by CXCR4 chemokine receptor signaling to ZAP-70 tyrosine kinase.
J Immunol.
2001;167:1857-1861 14. Zhang W, Sloan-Lancaster J, Kitchen J, Trible RP, Samelson LE. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell. 1998;92:83-92[CrossRef][Medline] [Order article via Infotrieve].
15.
Ganju RK, Brubaker SA, Meyer J, et al.
The
16.
Vicente-Manzanares M, Rey M, Jones DR, et al.
Involvement of phosphatidylinositol 3-kinase in stromal cell-derived factor-1 alpha-induced lymphocyte polarization and chemotaxis.
J Immunol.
1999;163:4001-4012
17.
Donovan JA, Wange RL, Langdon WY, Samelson LE.
The protein product of the c-Cbl protooncogene is the 120-kDa tyrosine-phosphorylated protein in Jurkat cells activated via the T cell antigen receptor.
J Biol Chem.
1994;269:22921-22924
18.
Turner SJ, Domin J, Waterfield MD, Ward SG, Westwick J.
The CC chemokine monocyte chemotactic peptide-1 activates both the class I p85/p110 phosphatidylinositol 3-kinase and the class II PI3K-C2
19.
Gulbins E, Coggeshall KM, Baier G, Katzav S, Burn P, Altman A.
Tyrosine kinase-stimulated guanine nucleotide exchange activity of Vav in T cell activation.
Science.
1993;260:822-825
20.
Feigelson SW, Grabovsky V, Winter E, et al.
The Src kinase p56lck upregulates VLA-4 integrin affinity: implications for rapid spontaneous and chemokine-triggered T cell adhesion to VCAM-1 and fibronectin.
J Biol Chem.
2001;276:13891-13901 |
(CXCL12)-induced lymphoid cell chemotaxis
Top
Abstract
Introduction
), C (
). Chemokines bind to
receptors that are members of the 7 transmembrane-spanning domain
receptor family that use heterotrimeric G proteins to transduce signals
inside the cell. Receptor activation induces the release of G
5 M 2-ME (all from Life Technologies,
Paisley, United Kingdom). Prior to use, NK cells were serum- and
IL-2-starved for 18 hours by incubation in AIM-V medium (Life
Technologies). This was followed by depletion of contaminating
T cells by binding of the cells twice to Dynabeads coated with
anti-CD3 (Dynal, Oslo, Norway). The result was more than 90%
CD56+CD3
), Lck wt (
), or the
constitutively active Lck Tyr505Phe construct (
). All 3 constructs
were also cotransfected with a vector encoding Csk, as indicated in the
Figure. (A) The different transfectants were subjected to chemotaxis
assay toward CXCL12 (25 ng/mL). Mean ± SD of 2 experiments (12 filters). *P < .01 as compared with cells transfected
with Lck wt alone. (B) Lysates from transfected JCaM1.6 cells were
immunoblotted with either an anti-Lck antibody or an anti-HA antibody
to detect Csk.
, Vav, Itk, and the
p85 subunit of PI3 kinase, through its SH3 domain.